Atavistik Bio Appoints Oncology Clinical Development Leader Mohammad Hirmand, M.D. to Board of Directors
Dr. Hirmand brings more than 20 years of clinical development expertise as Atavistik Bio continues to advance its portfolio of oncology-focused precision allosteric small molecule therapeutics into the clinic CAMBRIDGE, Mass., Sept. 25, 2024 (GLOBE …